Immuno Oncology Talks
Targeting Neutrophils as effector cells in cancer therapy
13 joulukuun, 2022
00:25:24
Speaker(s)
Prof. Marjolein van Egmond
The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond specializes in the innate immune system and is focusing on elucidating the therapeutic potential of neutrophils in cancer, with a specific interest in IgA and bispecific antibodies to activate the neutrophils.
For more information please visit:
Sanofi Immuno Oncology Talks website
MAT-BE-2200978 (ver. 1.0) 12 2022
Also interesting...
Immuno oncology, Multiple Myeloma
Hypogammaglobulinemia newsletter
Immuno oncology
Oncogenes in relation to immune responses
Immuno oncology
Cancer Immunotherapy and the role of Microbiome
Immuno oncology
Therapeutic RNA vaccines in cancer Immunotherapy
Immuno oncology